BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Seymour ML, Binion DG, Compton SJ, Hollenberg MD, MacNaughton WK. Expression of proteinase-activated receptor 2 on human primary gastrointestinal myofibroblasts and stimulation of prostaglandin synthesis. Can J Physiol Pharmacol. 2005;83:605-616. [PMID: 16091786 DOI: 10.1139/y05-046] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Rokonay R, Veres-Székely A, Szebeni B, Pap D, Lippai R, Béres NJ, Veres G, Szabó AJ, Vannay Á. Role of IL-24 in the mucosal remodeling of children with coeliac disease. J Transl Med 2020;18:36. [PMID: 31973719 DOI: 10.1186/s12967-020-02221-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Hagras MM, Kamel FO. Effect of Protease-Activated Receptor-2-Activating Peptide on Guinea Pig Airway Resistance and Isolated Tracheal Strips. J Microsc Ultrastruct 2020;8:7-13. [PMID: 32166058 DOI: 10.4103/JMAU.JMAU_55_18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
3 Heuberger DM, Schuepbach RA. Protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases. Thromb J 2019;17:4. [PMID: 30976204 DOI: 10.1186/s12959-019-0194-8] [Cited by in Crossref: 61] [Cited by in F6Publishing: 89] [Article Influence: 20.3] [Reference Citation Analysis]
4 Szűcs D, Béres NJ, Rokonay R, Boros K, Borka K, Kiss Z, Arató A, Szabó AJ, Vannay &, Sziksz E, Bereczki C, Veres G. Increased duodenal expression of miR-146a and -155 in pediatric Crohn’s disease. World J Gastroenterol 2016; 22(26): 6027-6035 [PMID: 27468194 DOI: 10.3748/wjg.v22.i26.6027] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
5 Baruah A, Buttar N, Chandra R, Chen X, Clemons NJ, Compare D, El-rifai W, Gu J, Houchen CW, Koh SY, Li W, Nardone G, Phillips WA, Sharma A, Singh I, Upton MP, Vega KJ, Wu X. Translational research on Barrett's esophagus: Translational research on Barrett's esophagus. Ann N Y Acad Sci 2014;1325:170-86. [DOI: 10.1111/nyas.12531] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
6 Kugler EM, Mazzuoli G, Demir IE, Ceyhan GO, Zeller F, Schemann M. Activity of protease-activated receptors in primary cultured human myenteric neurons. Front Neurosci. 2012;6:133. [PMID: 22988431 DOI: 10.3389/fnins.2012.00133] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
7 Scaldaferri F, Lancellotti S, Pizzoferrato M, Cristofaro RD. Haemostatic system in inflammatory bowel diseases: New players in gut inflammation. World J Gastroenterol 2011; 17(5): 594-608 [PMID: 21350708 DOI: 10.3748/wjg.v17.i5.594] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
8 Amiable N, Martel-Pelletier J, Lussier B, Kwan Tat S, Pelletier JP, Boileau C. Proteinase-activated receptor-2 gene disruption limits the effect of osteoarthritis on cartilage in mice: a novel target in joint degradation. J Rheumatol 2011;38:911-20. [PMID: 21285164 DOI: 10.3899/jrheum.100710] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
9 Hyun E, Andrade-Gordon P, Steinhoff M, Beck PL, Vergnolle N. Contribution of bone marrow-derived cells to the pro-inflammatory effects of protease-activated receptor-2 in colitis. Inflamm Res 2010;59:699-709. [PMID: 20339899 DOI: 10.1007/s00011-010-0181-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
10 Christerson U, Keita AV, Söderholm JD, Gustafson-Svärd C. Increased expression of protease-activated receptor-2 in mucosal mast cells in Crohn's ileitis. J Crohns Colitis 2009;3:100-8. [PMID: 21172252 DOI: 10.1016/j.crohns.2008.11.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
11 Borensztajn K, Peppelenbosch MP, Spek CA. Coagulation factor Xa signaling: the link between coagulation and inflammatory bowel disease? Trends in Pharmacological Sciences 2009;30:8-16. [DOI: 10.1016/j.tips.2008.10.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
12 Lin CB, Chen N, Scarpa R, Guan F, Babiarz-Magee L, Liebel F, Li WH, Kizoulis M, Shapiro S, Seiberg M. LIGR, a protease-activated receptor-2-derived peptide, enhances skin pigmentation without inducing inflammatory processes. Pigment Cell Melanoma Res 2008;21:172-83. [PMID: 18426410 DOI: 10.1111/j.1755-148X.2008.00441.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
13 Christerson U, Keita AV, Söderholm JD, Gustafson-Svärd C. Potential role of protease-activated receptor-2-stimulated activation of cytosolic phospholipase A(2) in intestinal myofibroblast proliferation: Implications for stricture formation in Crohn's disease. J Crohns Colitis 2009;3:15-24. [PMID: 21172243 DOI: 10.1016/j.crohns.2008.10.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
14 Ramachandran R, Hollenberg MD. Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more. Br J Pharmacol 2008;153 Suppl 1:S263-82. [PMID: 18059329 DOI: 10.1038/sj.bjp.0707507] [Cited by in Crossref: 149] [Cited by in F6Publishing: 175] [Article Influence: 9.9] [Reference Citation Analysis]